piper

BMS-1166-N-piperidine-CO-N-piperazine dihydrochloride, a resorcinol di-Ph ether scaffold-based programmed cell death-1 (PD-1) programmed cell death ligand 1 (PD-L1) inhibitor, inhibits the PD-1 PD-L1 interaction with an IC50 of 39.2 nM. It contains the target protein PD-1 PD-L1 ligand and PROTAC linker, which can be used to synthesize PROTAC PD-1 PD-L1 degrader-1 and has anticancer activity. Additionally, it serves as a diluent for the preparation of tablets for direct compression.

N-piperidine Ibrutinib is a potent BTK inhibitor with IC50s of 51.0 for WT BTK and 30.7 nM for C481S BTK respectively. N-piperidine Ibrutinib can be used as a BTK ligand in the synthesis of a series of PROTACs, such as SJF620. SJF620 is a potent PROTAC BTK degrader with a DC50 of 7.9 nM.

N-piperidine Ibrutinib hydrochloride is a potent BTK inhibitor, a BTK ligand, inhibits WT BTK and C481S BTK, which can be used to synthesize a range of PROTAC molecules.N-piperidine Ibrutinib hydrochloride has potential anticancer N-piperidine Ibrutinib hydrochloride has potential anticancer activity, inhibiting the growth and proliferation of cancer cells.

Navitoclax-piperazine (ABT-263-piperazine) is a B-cell lymphoma extra large (BCL-XL) inhibitor.

A-1210477-piperazinyl is a compound that specifically targets and binds to the protein myeloid cell leukemia 1 (MCL1) [myeloid cell leukemia 1]. This compound is utilized in PROTAC technology, harnessing the ability to selectively degrade target proteins.

Thalidomide-O-C5-piperidine-NH-Boc serves as an E3 Ligase Ligand-Linker Conjugate. This compound is utilized in the synthesis of PROTAC PIN1 degrader-1.

Thalidomide-piperidine is an E3 ubiquitin ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugates) that can be utilized in the synthesis of SMART1.

Thalidomide-N-methylpiperazine functions as an E3 Ligase Ligand-Linker Conjugate and is instrumental in the synthesis of PROTAC MLKL Degrader-2. This compound demonstrates antinecroptotic activity in human cell lines and effectively degrades MLKL in the HT-29 xenograft mouse model.

Lenalidomide-C13-piperazine-Boc is a conjugate of an E3 ligase ligand and linker used in synthesizing the PROTAC degrader NC-R17.

Thalidomide-piperidine-CO-piperazine-C-3-Br-Ph is a type of E3 ubiquitin ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugates). It is utilized in the synthesis of PROTAC SMARCA2 degrader-28.

Acepromazine-1-Piperazinepropanamine (compound 10) is an E3 ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugate) consisting of a cereblon ligand and a linker. This compound can target protein ligands to form the PROTAC molecule, TrimTAC1.

(R)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 serves as the E3 ubiquitin ligase ligand and linker for PROTAC(R)-NX-2127, utilized in cancer research.

(3S)Lenalidomide-piperazine-C-piperidine is an E3 ubiquitin ligase ligand-linker conjugate (E3 Ligase Ligand-Linker Conjugates). This compound can be utilized in the synthesis of PROTAC ER Degrader-11.

Lenalidomide-6-F-piperidine-C2-Pip-C-COOH acts as a linker and an E3 ligase ligand for PROTACBTKDegrader-5, utilized in the study of malignant lymphomas.

Piperidine-C2-Pip-C-COOH serves as a linker for PROTAC BTK Degrader-5, significantly enhancing metabolic stability for use in cancer research.

Thalidomide-piperidine-C2-piperazine-Boc is an E3 Ligase Ligand-linker conjugate comprising a cereblon ligand based on Thalidomide and a linker. This compound is utilized in the synthesis of PROTAC.

(S)-Thalidomide-pyrrolidine-C-piperidine-Ph-NH2 is a conjugate that serves as both an E3 ubiquitin ligase ligand and a linker for NX-2127.

Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH (Compound C6) is a conjugate linking a ligand and an E3 ligase, which is utilized in the synthesis of PROTAC PARP1 degrader-30.

Pomalidomide-benzyl-piperazine hydrochloride functions as a building block for creating targeted protein degraders and PROTACs. It contains a Cereblon (CRBN)-binding ligand, a stable linker, and a pendant amine that can react with a carboxylic acid on the target ligand.

'PAG 4'-piperazine-4-methylpiperidine is a specialized cereblon ligand employed in PROTAC research and development. It includes an E3 ligase ligand and a terminal piperidine, allowing for further chemical modifications to produce Protein Degraders with rigid linkers. This compound is part of a suite of functionalized tool molecules used in PROTAC R&D.

Pomalidomide-pyridine-PEG1-piperazine hydrochloride is a key building block in the synthesis of targeted protein degraders and PROTACs. It features a Cereblon (CRBN)-recruiting ligand, a more rigid linker, and a pendant amine designed to react with a carboxylic acid on the target ligand.

Thalidomide-4-piperidineacetaldehyde is a conjugate of an E3 ubiquitin ligase ligand and linker, utilized in the synthesis of PROTAC H122.

3-(4-Bromo-2-fluorophenyl)piperidine-2,6-dione is a CRBN-type E3 ubiquitin ligase ligand, which can be used in the preparation of PROTACs.

3-(4-Bromo-2-chlorophenyl)piperidine-2,6-dione acts as a ligand for CRBN type E3 ubiquitin ligase and is useful in the synthesis of PROTAC.